Adherence to antihypertensive medications and health outcomes among newly treated hypertensive patients
Open Access
- 1 March 2011
- journal article
- Published by Taylor & Francis Ltd in ClinicoEconomics and Outcomes Research
- Vol. 3, 47-54
- https://doi.org/10.2147/CEOR.S15619
Abstract
Objective: To evaluate adherence to antihypertensive therapy (AHT) and the association between adherence to AHT, all-cause mortality, and cardiovascular (CV) morbidity in a large cohort of patients newly treated with antihypertensives in a clinical practice setting. Methods: An administrative database kept by the Local Health Unit of Florence (Italy) listing patient baseline characteristics, drug prescription, and hospital admission information was used to perform a population-based retrospective study including patients newly treated with antihypertensives, ≥18 years of age, with a first prescription between January 1, 2004 and December 31, 2006. Patients using antihypertensives for secondary prevention of CV disease, occasional spot users, and patients with early CV events, were excluded from the study cohort. Adherence to AHT was calculated and classified as poor, moderate, good, and excellent. A Cox regression model was conducted to determine the association among adherence to AHT and risk of all-cause mortality, stroke, or acute myocardial infarction. Results: A total of 31,306 patients, 15,031 men (48.0%), and 16,275 women (52.0%), with a mean age of 60.2 ± 14.5 years was included in the study. Adherence to AHT was poor in 8038 patients (25.7% of included patients), moderate in 4640 (14.8%), good in 5651 (18.1%), and excellent in 12,977 (41.5%). Compared with patients with poor adherence (hazard ratio [HR] = 1), the risk of all-cause death, stroke, or acute myocardial infarction was significantly lower in patients with good (HR = 0.69, P < 0.001) and excellent adherence (HR = 0.53, P< 0.001). Conclusions: These findings indicate that suboptimal adherence to AHT occurs in a substantial proportion of patients and is associated with poor health outcomes already in primary prevention of CV diseases. For health authorities, this preliminary evidence underlines the need for monitoring and improving medication adherence in clinical practice.Keywords
This publication has 30 references indexed in Scilit:
- Adherence to Antihypertensive Medications and Cardiovascular Morbidity Among Newly Diagnosed Hypertensive PatientsCirculation, 2009
- Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studiesBMJ, 2009
- Prognostic Stratification of Older Persons Based on Simple Administrative Data: Development and Validation of the "Silver Code," To Be Used in Emergency Department TriageThe Journals of Gerontology, Series A: Biological Sciences and Medical Sciences, 2009
- Impact of a Better Adherence to Antihypertensive Agents on Cerebrovascular Disease for Primary PreventionStroke, 2009
- Effects of different regimens to lower blood pressure on major cardiovascular events in older and younger adults: meta-analysis of randomised trialsBMJ, 2008
- Effect of Medication Nonadherence on Hospitalization and Mortality Among Patients With Diabetes MellitusArchives of Internal Medicine, 2006
- Impact of Medication Adherence on Hospitalization Risk and Healthcare CostMedical Care, 2005
- Pharmacoeconomic burden of undertreating hypertension.PharmacoEconomics, 2004
- Predictors of Long-term Persistence on Statins in a Subsidized Clinical PopulationValue in Health, 2000
- The use of claims databases for outcomes research: rationale, challenges, and strategiesClinical Therapeutics, 1997